Lilly Invests SGD $42M in Singapore for New Digital Health Innovation Hub
Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lilly and Company (Lilly), announced the establishment of a SGD$42 million Digital Health Innovation Hub in Singapore to accelerate the research and development of AI-powered digital health technologies.…
